Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Takeda's orally disintegrating Actos tablets approved in Japan for type 2 diabetes

Jan. 19, 2010

Novel PPAR agonists claimed by sanofi-aventis as antidiabetic agents

Jan. 19, 2010

European orphan drug status recommended for Protalix's taliglucerase alfa for GD

Jan. 19, 2010

Alogliptin equally effective in younger and elderly patients with type 2 diabetes

Jan. 19, 2010

Spherix completes enrollment into phase III trial of D-tagatose in type 2 diabetes

Jan. 19, 2010

Transdermal patch effectively delivers teriparatide in postmenopausal women with osteoporosis

Jan. 18, 2010

Premier Research begins phase II trial of Vantia's VA-111913 for menstrual cramps

Jan. 18, 2010

Novel sulfonylureas in development for diabetes therapy at Concert Pharmaceuticals

Jan. 15, 2010

Genfit reports results from phase I safety study of GFT-505/simvastatin combination

Jan. 15, 2010

Amicus Therapeutics presents development progress with Amigal

Jan. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...